美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Hydrocodone Bitartrate/Ibuprofen	Tablet	II (Paddle)	50	Phosphate Buffer, pH 7.2	900	5, 10, 15 and 30	2004/02/04
Hydrocortisone	Tablet			Develop a dissolution method			2024/01/03
Hydromorphone HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydromorphone HCl	Tablet (Extended Release)			Develop a dissolution method			2023/09/15
Hydroxychloroquine Sulfate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/04/16
Hydroxyurea	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydroxyurea	Tablet			Refer to FDA's Dissolution Guidance, 2018			2022/07/07
Hydroxyzine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydroxyzine Pamoate	Capsule			Refer to USP			2009/04/02
Hydroxyzine Pamoate	Suspension			Develop a dissolution method			2009/04/02
Ibandronate Sodium	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Ibrexafungerp Citrate	Tablet	II (Paddle)	50	0.1N HCl	900	10, 15, 20, 30 and 45	2023/02/09
Ibrutinib	Capsule	II (Paddle)	75	3.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8	900	5, 10, 20, 30 and 45	2015/06/25
Ibrutinib	Suspension	II (Paddle)	25	0.05 M potassium phosphate buffer, pH 6.8, w/ 1.5% (w/v) Tween 20	900	5, 10, 15, 20, 30, 45 and 60	2025/09/08
Ibrutinib (140 and 280 mg)	Tablet	II (Paddle)	75	3.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8	900	10, 20, 30, 45 and 60	2020/04/02
Ibrutinib (420 and 560 mg)	Tablet	II (Paddle)	75	6.0% w/v Polysorbate 20 in 50 mM Phosphate Buffer, pH 6.8	900	10, 20, 30, 45 and 60	2020/04/02
Ibuprofen	Capsule (Soft-Gelatin/Liquid Fill)	I (Basket)	150	50mM Phosphate Buffer, pH 7.2	900	5, 10, 20, 30 and 45	2013/05/09
Ibuprofen	Tablet (Chewable)	II (Paddle)	50	0.05 M Phosphate Buffer, pH 7.2	900	10, 20, 30 and 45	2004/02/04
Ibuprofen	Suspension			Refer to USP			2008/11/04
Ibuprofen	Suspension/Drop	II (Paddle)	50	Phosphate Buffer, pH 7.2	900	5, 10, 15 and 20	2008/11/04